AIP
TDOC icon

ARS Investment Partners’s Teladoc Health TDOC Stock Holding History

ARS Investment Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-950
Closed -$208K – 125
2020
Q3 		$208K Buy
+950
New +$201K 0.03% 98

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ARS Investment Partners's TDOC Position: Q4 2020 in Review

ARS Investment Partners sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 950 shares — an estimated $208K sold.

ARS Investment Partners first reported a position in TDOC in Q3 2020 and held it in 1 quarter. The position peaked at $208K in Q3 2020. 900 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

  • ARS Investment Partners reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
  • ARS Investment Partners sold 950 Teladoc Health shares in Q4 2020, an estimated $208K.
  • ARS Investment Partners first reported a position in Teladoc Health in Q3 2020 and held it in 1 quarter.
  • ARS Investment Partners's Teladoc Health position peaked at $208K in Q3 2020.
  • 900 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on ARS Investment Partners's 13F filing for Q4 2020, filed 9 Feb 2021.